Indeed, large-scale sequencing efforts encompassing thousands of CRC specimens have not identified JAK2 p.V617F mutations in tumor tissue, suggesting that this alteration is exceedingly rare or potentially absent from primary colorectal carcinogenesis (Herreros-Villanueva et al., 2010; Strickler et al., 2018). This evidence concerns the gene JAK2 and neoplasm.